The Role of Activation-Induced Cell Death in the Differentiation of T-Helper-Cell Subsets

Immunologic Research

Volumn 28, Issue 3, 2003, Pages 285-293

  Roberts, Arthur I ^a   Devadas, Satish ^a   Zhang, Xiaoren ^a   Zhang, Liying ^a   Keegan, Achsah ^a   Greeneltch, Kristy ^a   Solomon, Jennifer ^a   Wei, Lixin ^a   Das, Jyoti ^a   Sun, Erwei ^a   Liu, Catherine ^a   Yuan, Zengrong ^a   Zhou, Jian Nian ^a   Shi, Yufang ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

AICD; Apoptosis; Fas; T Cell; TRAIL

Indexed keywords

BIM PROTEIN; CYTOKINE RECEPTOR; DEATH RECEPTOR 3; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOTOXIN; MYC PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; AUTOCRINE EFFECT; CELL ACTIVATION; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURFACE; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOLYSIS; HELPER CELL; HUMAN; HUMORAL IMMUNITY; HYBRIDOMA; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MITOSIS INHIBITION; MOLECULAR MECHANICS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMOCYTE; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DIFFERENTIATION; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; TH1 CELLS; TH2 CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9144232224     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:28:3:285     Document Type: Review

References (78)

1. Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, et al.: Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 2000;88:333-347.
2. Habibovic S, Hrgovic Z, Bukvic I, Hrgovic I: [Molecular mechanisms in apoptosis]. Med Arh 2000;54:33-40.
3. Zimmermann KC, Bonzon C, Green DR: The machinery of programmed cell death. Pharmacol Ther 2001;92:57-70.
4. Duke RC, Ojcius DM, Young JD: Cell suicide in health and disease. Sci Am 1996;275:80-87.
5. Reed JC, Tomaselli KJ: Drug discovery opportunities from apoptosis research. Curr Opin Biotechnol 2000; 11:586-592.
6. Schmitz I, Kirchhoff S, Krammer PH: Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 2000;32:1123-1136.
7. McConkey DJ, Jondal M, Orrenius S: Cellular signaling in thymocyte apoptosis. Semin Immunol 1992;4: 371-377.
8. Green DR, Bissonnette RP, Glynn JM, Shi Y: Activation-induced apoptosis in lymphoid systems. Semin Immunol 1992;4:379-388.
9. Ashwell JD, Lu FW, Vacchio MS: Glucocorticoids in T cell development and function. Annu Rev Immunol 2000;18:309-345.
10. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen Y. H: Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL(-/-) mice. Nat Immunol 2003;10:10.
11. Chan KF, Siegel MR, Lenardo JM: Signaling by theTNF receptor superfamily and T cell homeostasis. Immunity 2000;13:419-422.
12. Scott DW: Analysis of B cell tolerance in vitro. Adv Immunol 1993;54:393-425.
13. Scott DW, Grdina T, Shi Y: T cells commit suicide, but B cells are murdered! J Immunol 1996;156:2352-2356.
14. Green DR, Scott DW: Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 1994;6:476-487.
15. Henkart PA, Williams MS, Zacharchuk CM, Sarin A: Do CTL kill target cells by inducing apoptosis? Semin Immunol 1997;135-144.
16. Trapani JA, Sutton VR, Smyth MJ: CTL granules: evolution of vesicles essential for combating virus infections. Immunol Today 1999;20:351-356.
17. Shi YF, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR: In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol 1991;146:3340-3346.
18. Shi YF, Sahai BM, Green DR: Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 1989;339:625-626.
19. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989;337:181-184.
20. Jenkinson EJ, Kingston R, Smith CA, Williams GT, Owen JJ: Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol 1989;19:2175.
21. Murphy KM, Heimberger AB, Loh DY: Induction by antigen of intrathymic apoptosis of CD4+CD8+TCR1o thymocytes in vivo. Science 1990;250:1720-1723.
22. Sytwu HK, Liblau RS, McDevitt HO: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996;5:17-30.
23. Hamad AR, Schneck JP: Antigen-induced T cell death is regulated by CD4 expression. Int Rev Immunol 2001;20:535-546.
24. Mercep M, Bluestone JA, Noguchi PD, Ashwell JD: Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J Immunol 1988;140:324-335.
25. Shi YF, Szalay MG, Paskar L, Sahai BM, Boyer M, Singh B, et al.: Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol 1990;144:3326-3333.
26. Boehme SA, Lenardo MJ: Ligand-induced apoptosis of mature T lymphocytes (propriocidal regulation) occurs at distinct stages of the cell cycle. Leukemia 1993; 7 Suppl 2:S45-S49.
27. Lenardo MJ: Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991;353:858-861.
28. Tough DF, Sprent J: Life span of naive and memory T cells. Stem Cells 1995;13:242-249.
29. Sprent J, Tough DF: Lymphocyte life-span and memory. Science 1994;265:1395-1400.
30. Levine BL, Bernstein WB, Connors M, Craighead N, Lindsten T, Thompson CB, et al.: Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol 1997;159:5921-5930.
31. Breitmeyer JB, Oppenheim SO, Daley JF, Levine HB, Schlossman SF: Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. J Immunol 1987;138:726-731.
32. Nau GJ, Moldwin RL, Lancki DW, Kim DK, Fitch FW: Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody. J Immunol 1987;139:114-122.
33. Webb SR, Li JH, MacNeil I, Marrack P, Sprent J,Wilson DB: T cell receptors for responses to Mls determinants and allo-H-2 determinants appear to be encoded on different chromosomes. J Exp Med 1985;161:269-274.
34. Bensussan A, Leca G, Corvaia N, Boumsell L: Selective induction of autocytotoxic activity through the CD3 molecule. Eur J Immunol 1990;20:2615-2619.
35. Janssen O, Sanzenbacher R, Kabelitz D: Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res 2000;301:85-99.
36. Kabelitz D, Janssen O: Antigen-induced death of T-Lymphocytes. Front Biosci 1997;2:d61-77.
37. Janssen O, Wesselborg S, Kabelitz D: Immunosuppression by OKT3 - induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation 1992;53:233-234.
38. Russell JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995;7:382-388.
39. Baumann S, Krueger A, Kirchhoff S, P. Krammer H: Regulation of T cell apoptosis during the immune response. Curr Mol Med 2002;2:257-272.
40. Mountz JD, Zhou T, Su X, Cheng J, Pierson M, Bluethmann H, et al.: Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Inst Mitt: 1996;200-219.
41. Donjerkovic D, Scott DW: Activation-induced cell death in B lymphocytes. Cell Res 2000;10:179-192.
42. Kishimoto H, Surh CD, Sprent J: A role for Fas in negative selection of thymocytes in vivo. J Exp Med 1998; 187:1427-1438.
43. Zhou T, Edwards CK 3rd, Mountz JD: Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995;182:129-137.
44. Simon AK, Williams O, Mongkolsapaya J, Jin B, Xu XN, Walczak H, et al.: Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc Natl Acad Sci USA 2001;98:5158-5163.
45. Wang EC, Thern A, Denzel A, Kitson J, Farrow SN, Owen MJ: DR3 regulates negative selection during thymocyte development. Mol Cell Biol 2001;21:3451-3461.
46. Tamada K, Ni J, Zhu G, Fiscella M, Teng B, van Deursen JM, et al.: Cutting edge: selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT. J Immunol 2002;168:4832-4835.
47. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H, et al.: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002;415:922-926.
48. Van Parijs L, Abbas AK: Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996;8:355-361.
49. Van Parijs L, Ibraghimov A, Abbas AK: The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996;4:321-328.
50. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, et al.: Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-165.
51. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, et al.: Cell-autonomous Fas (CD95)/ Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373: 441-444.
52. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, et al.: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
53. Ettinger R, Panka DJ, Wang JK, Stanger BZ, Ju ST, Marshak-Rothstein A: Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J Immunol 1995;154:4302-4308.
54. Pawelec G, Sansom D, Rehbein A, Adibzadeh M, Beckman I: Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol 1996;31:655-668.
55. Orchansky PL, Teh HS: Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/CD3 subunits. J Immunol 1994;153:615-622.
56. Wang R, Ciardelli TL, Russell JH: Partial signaling by cytokines: cytokine regulation of cell cycle and Fas-dependent, activation-induced death in CD4+ subsets. Cell Immunol 1997;182:152-160.
57. Boehme SA, Lenardo MJ: Propriocidal apoptosis of matureT lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 1993;23:1552-1560.
58. Wang R, Brunner T, Zhang L, Shi Y: Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression. Oncogene 1998;17:1503-1508.
59. Zhang XR, Zhang LY, Li L, Glimcher LH, Keegan AD, Shi YF: Reciprocal Expression of TRAIL and CD95L in Th1 and Th2 Cells: Role of Apoptosis in T Helper Subset Differentiation. Cell Death and Differentiation 2003;10:201-210.
60. Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O: Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell Immunol 1997;181: 93-100.
61. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994;6:1545-1553.
62. Kim J, Woods A, Becker-Dunn E, Bottomly K: Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med 1985;162:188-201.
63. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136: 2348-2357.
64. Murphy KM: T lymphocyte differentiation in the periphery. Curr Opin Immunol 1998;10:226-236.
65. Miner KT, Croft M: Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma. J Immunol 1998;160:5280-5287.
66. Constant SL, Bottomly K: Induction of Th1 and Th2 CD4+T cell responses: the alternative approaches. Annu Rev Immunol 1997;15:297-322.
67. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
68. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 1994;76:241-251.
69. Farrar JD, Ouyang W, Lohning M, Assenmacher M, Radbruch A, Kanagawa O, et al.: An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J Exp Med 2001;193:643-650.
70. Kamogawa Y, Minasi LA, Carding SR, Bottomly K, Flavell RA: The relationship of IL-4-and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 1993;75:985-995.
71. Naramura M, Kole HK, Hu RJ, Gu H: Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA 1998;95: 15547-15552.
72. Riviere I, Sunshine MJ, Littman D. R: Regulation of IL-4 expression by activation of individual alleles. Immunity 1998;9:217-228.
73. Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P: Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci U S A 1997;94:5778-5783.
74. Accornero P, Radrizzani M, Delia D, Gerosa F, Kurrle R, Colombo MP: Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. Blood 1997;89:558-569.
75. Watanabe N, Arase H, Kurasawa K, Iwamoto I, Kayagaki N, Yagita H, et al.: Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur J Immunol 1997;27:1858-1864.
76. Zhou T, Mountz JD, Kimberly RP: Immunobiology of tumor necrosis factor receptor superfamily. Immunol Res 2002;26:323-336.
77. Secchiero P, Gonelli A, Celeghini C, Mirandola P, Guidotti L, Visani G, et al.: Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Blood 2001;98:2220-2228.
78. Martinez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Pineiro A, et al.: Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 1998;28:2714-2725.